top of page

Our Services

BioHorizon Strategies brings cross-cutting expertise across numerous therapeutic modalities. Combined with our subject matter knowledge and project experience across a broad disease landscape, we enable nuanced insights across R&D strategy, Corporate Strategy, and Business Development.​

R&D Strategy

  • Asset development feasibility

  • Preclinical strategy & execution

  • Roadmaps / gap analysis

Corporate Strategy

  • Indication opportunity mapping, prioritization

  • Competitive intensity / landscaping

  • New product planning

  • Target product profile

Business Development

  • Asset search & evaluation

  • Due diligence

  • Partnering / M&A

  • Asset valuation

  • Pitch decks / fundraising

​Modalities:

​

  • Small molecules

  • Monoclonal antibodies, bispecifics, ADCs

  • Circular RNA, mRNA, RNAi, etc.

  • Antisense oligonucleotides

  • Peptides

  • Viral and nonviral vectors

  • Gene and cell therapies / editing​

  • Platform technologies

​Disease Areas:

​​

  • ​Immunology and inflammation

  • Cardiovascular

  • Gastroenterology and liver

  • Ophthalmology

  • Rare diseases

  • Oncology

  • Fibrosis

  • Infectious diseases

  • Neurodegeneration

bottom of page